Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Coronavirus

<< Previous

Bullboard Posts

Next >>

Comment by Mikee3003on Aug 19, 2020 9:40am

170 Views

Post# 31427519

RE:Coronavirus

Great news....thinking of some other studies that could possibly tie into this. Say someone with Non-Hodgkins Lymphoma comes down with Covid and is eligible to be treated with TLT PDC's. Folicular lymphoma for example is often treated with low dose external beam radiation therapy so could this be used to activate the PDC's and knockout the covid virus along with the cancer?? Exciting possibilities!
GLTA

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects